Skip to main content
. 2026 Mar 27;59:101155. doi: 10.1016/j.ctro.2026.101155

Table 3.

Mortality rates across trial groups.

Variable Standard regimen (41.4 Gy) Intensified Regimen (50.4 Gy) P-value
Overall Mortality 18 (52.9%) 20 (55.6%) 0.826a
Mortality from the start of chemoradiotherapy until one month after its completion 3 (8.8%) 4 (11.1%) 0.999b
Post-operation Mortality 5 (21.7%) 3 (14.3%) 0.701b

P-value of < 0.05 was considered statistically significant;

a

Chi-squared test.

b

Fisher's Exact test.